Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Janke

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2024
Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 PromiscuityAlexandra A Abu-Shmais, Rose J Miller, Alexis K Janke, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.
Cell Reports. Medicine|January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Generation of antigen-specific paired chain antibody sequences using large language modelsPerry T Wasdin, Nicole V Johnson, Alexis K Janke, et al.
Cell|November 5, 2025
Generation of antigen-specific paired-chain antibodies using large language modelsPerry T Wasdin, Nicole V Johnson, Alexis K Janke, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2024
Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 PromiscuityAlexandra A Abu-Shmais, Rose J Miller, Alexis K Janke, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.
Cell Reports. Medicine|January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Generation of antigen-specific paired chain antibody sequences using large language modelsPerry T Wasdin, Nicole V Johnson, Alexis K Janke, et al.
Cell|November 5, 2025
Generation of antigen-specific paired-chain antibodies using large language modelsPerry T Wasdin, Nicole V Johnson, Alexis K Janke, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Pageof 9